NanoVibronix Says PainShield Is Not Reimbursable Under Medicare And Medicaid At This Time; Reports Disappointment With The Recent Decision From CMS
Portfolio Pulse from Benzinga Newsdesk
NanoVibronix has announced that its PainShield product is not currently reimbursable under Medicare and Medicaid. The company expressed disappointment with the recent decision from the Centers for Medicare & Medicaid Services (CMS).
August 29, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NanoVibronix's PainShield product is not currently reimbursable under Medicare and Medicaid, which could potentially impact the company's sales and revenues.
The decision by CMS not to reimburse NanoVibronix's PainShield product under Medicare and Medicaid could potentially limit the product's market reach and negatively impact the company's sales and revenues. This is particularly relevant as Medicare and Medicaid are major healthcare programs in the US, and their coverage decisions can significantly influence product uptake and sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100